ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
BrainStorm Announces NurOwn Expanded Access Program americanpharmaceuticalreview
January 05, 2021BrainStorm Cell Therapeutics has announced the initiation of a NurOwn? (MSC-NTF cells) Expanded Access Program (EAP) for patients with amyotrophic lateral sclerosis (ALS) who completed the Company's recently concluded pivotal Phase 3 clinical trial ...
Pharma Sources Insight January 2025
